Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.
Embo Molecular Medicine
Her, Zhisheng Z; Teng, Terk-Shin TS; Tan, Jeslin J L JJ; Teo, Teck-Hui TH; Kam, Yiu-Wing YW; Lum, Fok-Moon FM; Lee, Wendy W L WW; Gabriel, Christelle C; Melchiotti, Rossella R; Andiappan, Anand K AK; Lulla, Valeria V; Lulla, Aleksei A; Win, Mar K MK; Chow, Angela A; Biswas, Subhra K SK; Leo, Yee-Sin YS; Lecuit, Marc M; Merits, Andres A; Rénia, Laurent L; Ng, Lisa F P LF
Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study.
Mutation Research
Slattery, Martha L ML; Lundgreen, Abbie A; Torres-Mejia, Gabriela G; Wolff, Roger K RK; Hines, Lisa L; Baumgartner, Kathy K; John, Esther M EM
Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.
Clinical And Vaccine Immunology : Cvi
Moore, Catrin E CE; Hennig, Branwen J BJ; Perrett, Kirsten P KP; Hoe, J Claire JC; Lee, Sue J SJ; Fletcher, Helen H; Brocklebank, Denise D; O'Connor, Daniel D; Snape, Matthew D MD; Hall, Andrew J AJ; Segal, Shelley S; Hill, Adrian V S AV; Pollard, Andrew J AJ
Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.
Human Genetics
Ovsyannikova, Inna G IG; Dhiman, Neelam N; Haralambieva, Iana H IH; Vierkant, Robert A RA; O'Byrne, Megan M MM; Jacobson, Robert M RM; Poland, Gregory A GA